InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Talasaz AmirAli, Chairman & CEO. Director active across 1 companies, notably Guardant Health, Inc.. Aggregated, 4 disclosures have been published. Total volume traded: €6.5m. The latest transaction was filed on 19 November 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€3m37,721 shares@ €86.04760.026% mcap97.4% of flow
COMMON STOCK
SEC:0001576280-21-000108·
Ideal exit: 16 Aug 2022 (T+270)
€3m37,721 shares@ €86.04760.026% mcap48.7% of flow
COMMON STOCK
SEC:0001576280-21-000108:0·
Ideal exit: 16 Aug 2022 (T+270)
€85,20423,923 shares@ €3.56160.0007% mcap2.6% of flow
COMMON STOCK
SEC:0001576280-21-000087·
€85,20423,923 shares@ €3.56160.0007% mcap1.3% of flow
COMMON STOCK
SEC:0001576280-21-000087:0·
4 of 4 declarations
About Talasaz AmirAli
AmirAli Talasaz is the Co-Chief Executive Officer of Guardant Health, Inc., a company specializing in cancer diagnostics. In this role, he oversees the company's operations and drives strategic initiatives. With expertise in the healthcare sector, he is committed to promoting innovation and strengthening the company's market position.
